Veterinary Medicines

Rycarfa 20 mg tablets for dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Rycarfa 20 mg tablets for dogs
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    20.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Blister (OPA/Al/PVC-Al): 20 tablets (10 tablets/blister) in a box.
  • Blister (OPA/Al/PVC-Al): 50 tablets (10 tablets/blister) in a box.
  • Blister (OPA/Al/PVC-Al): 100 tablets (10 tablets/blister) in a box.
  • Blister (OPA/Al/PVC-Al): 500 tablets (10 tablets/blister) in a box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
  • Tad Pharma GmbH
  • Krka-Farma d.o.o.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • 01656/4069
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0316/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."